EGFR and esophageal squamous cell carcinoma: In NSCLC, the mechanism of synergistic interaction was also suggested to be due to increased docetaxel-induced phosphorylation of EGFR and its subsequent inhibition following gefitinib addition [6]; however, similar analysis of our ESCC cell lines over several repeat experiments was inconclusive.